Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
190.00
Ask:
198.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

H1 2023 Trading Update

11 Jul 2023 07:00

RNS Number : 5538F
Norman Broadbent PLC
11 July 2023
Β 

11 July 2023

Norman Broadbent plc

("Norman Broadbent" or the "Company")

Β 

H1 2023 TRADING UPDATE

Norman Broadbent (AIM: NBB), a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, is pleased to announce the following unaudited trading update for the 6 months ended 30 June 2023 ("H1 2023").

Β 

Financial highlights

Β· Strong recent growth in net fee income ("NFI") has continued with H1 2023 up 57% to Β£5.2m (H1 2022: Β£3.3m).

oΒ  Q2 2023 NFI of Β£2.7m was up 50% on Q2 2022 (Q2 2022: Β£1.8m).

oΒ  Executive Search NFI grew by 58% to Β£4.1m (H1 2022: Β£2.6m). This growth is reflective of the improvements in culture, brand, headcount growth and quality and seniority of mandates secured by the Company.

oΒ  Interim Management NFI was Β£1.0m, up 43% on prior year (H1 2022: Β£0.7m).Β 

Β· Β£1.0m of NFI generated in June 2023 alone.

Β· H1 2023 EBITDA is expected to be in excess of Β£0.25m (H1 2022: Β£0.05m).

Β· The pipeline of contracted work continues to remain strong with Β£2.3m of contracted revenue in place going into Q3 2023 (30 June 2022: Β£1.0m).

Β· Average new search fee value increased by 43% and average NFI per fee earner up 13% compared to H1 2022.Β 

Β· 35% growth in fee earner headcount since 30 June 2022.

Β· Implementation of improved technology platforms in 2023 with new finance system, HR platform and expense management tool, all of which will provide improved management information and opportunity for rapid expansion.

Β 

Norman Broadbent expects to announce its unaudited interim results for H1 2023 later this month.

Kevin Davidson, Group CEO of Norman Broadbent, commented:

"We are delighted with the progress the entire business continues to make. Our considerable growth in NFI is translating into positive EBITDA and greatly improved financial performance whilst we continue to invest heavily in business transformation. Having joined the Company in September 2021, a year in which Norman Broadbent delivered a total of Β£5.8 million NFI, it is very pleasing to see our NFI in H1 2023 alone standing at Β£5.2 million. This demonstrates just how far the business has come in a relatively short period.

Despite the challenging macro-economic conditions, we have, for some time, believed that the Company is well positioned in the correct markets at the appropriate level to ensure continued growth and success. We are very much on track to deliver on our target of Β£1.25 million EBITDA by 2025."

Β 

Β 

For further Information, please contact:

Norman Broadbent plcΒ Β  020 7484 0000

Kevin Davidson, CEO

Mehr Malik, CFO

Shore Capital (Nominated Adviser and Broker) 020 7408 4090

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTSFEFMSEDSEFW
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.